Aniko Szabo, PhD

Professor

Locations

Biostatistics

Contact Information

Education

PhD - Applied Statistics, University of Memphis, Memphis, TN, 1998
MS - Statistics, University of Memphis, Memphis, TN, 1997
MS - Mathematics, Eötvös University, Budapest, Hungary, 1994

Research Experience

Mathematical Modeling of Cancer Screening and Oncogenesis.

Leadership Positions

Director of the Biostatistics Consulting Center

Research Interests

Dr. Aniko Szabo is an Associate Professor and Director of the Biostatistics Consulting Service. Dr. Szabo's research interests are in statistical modeling of biomedical data. She has worked on analysis methods for PCR and microarray data, developing tree models of oncogenesis, nonparametric models of clustered discrete data, and population level models of the effect of screening on prostate cancer incidence. She collaborates with biomedical investigators across the entire spectrum of translational research from analyzing cellular assays, animal experiments, and observational studies in patients to designing prospective clinical trials and evaluation of policy impacts in national databases.

Curriculum Vitae

Vaccination Against SARS-CoV-2 Decreases Risk of Adverse Events in Patients who Develop COVID-19 Following Cancer Surgery.

(Verhagen NB, Koerber NK, Szabo A, Taylor B, Wainaina JN, Evans DB, Kothari AN, N3C Consortium.) Ann Surg Oncol. 2023 Mar;30(3):1305-1308 PMID: 36479662 PMCID: PMC9734328 SCOPUS ID: 2-s2.0-85143492422 12/09/2022
Reply to Letter to Editor by Vig A, et al.

(Bowder AN, Szabo A, Lal DR.) J Pediatr Surg. 2023 Mar;58(3):596 PMID: 36384940 SCOPUS ID: 2-s2.0-85147833856 11/18/2022
A cross-sectional study of patient-reported outcomes and symptom burden using PROMIS and PRO-CTCAE measures in light chain amyloidosis.

(D'Souza A, Szabo A, Akinola I, Finkel M, Flynn KE.) Qual Life Res. 2023 Feb 04 PMID: 36738402 SCOPUS ID: 2-s2.0-85147351523 02/05/2023
Associations between socioeconomic status and bispecific LV20.19 CAR T-cell therapy outcomes.

(Knight JM, Hackett E, Szabo A, Wu R, Sauber G, Johnson B, Cusatis RN, Aughey E, Cole SW, Hillard CJ, Shah NN.) Haematologica. 2023 Feb 01;108(2):588-593 PMID: 36200427 PMCID: PMC9890001 SCOPUS ID: 2-s2.0-85147234722 10/07/2022
Multimedia tablet or paper handout to supplement counseling during preterm birth hospitalization.

(Rau NM, Mcintosh JJ, Flynn KE, Szabo A, Ahamed SI, Asan O, Hasan MK, Basir MA.) Am J Obstet Gynecol MFM. 2023 Jan 26;5(4):100875 PMID: 36708966 01/29/2023
Thoracoscopy versus thoracotomy for esophageal atresia and tracheoesophageal fistula: Outcomes from the Midwest Pediatric Surgery Consortium.

(Marquart JP, Bowder AN, Bence CM, St Peter SD, Gadepalli SK, Sato TT, Szabo A, Minneci PC, Hirschl RB, Rymeski BA, Downard CD, Markel TA, Deans KJ, Fallat ME, Fraser JD, Grabowski JE, Helmrath MA, Kabre RD, Kohler JE, Landman MP, Lawrence AE, Leys CM, Mak GZ, Port E, Saito J, Silverberg J, Slidell MB, Wright TN, Lal DR, Midwest Pediatric Surgery Consortium.) J Pediatr Surg. 2023 Jan;58(1):27-33 PMID: 36283849 SCOPUS ID: 2-s2.0-85140623503 10/26/2022
Predicting Neoadjuvant Treatment Response in Rectal Cancer Using Machine Learning: Evaluation of MRI-Based Radiomic and Clinical Models.

(Peterson KJ, Simpson MT, Drezdzon MK, Szabo A, Ausman RA, Nencka AS, Knechtges PM, Peterson CY, Ludwig KA, Ridolfi TJ.) J Gastrointest Surg. 2023 Jan;27(1):122-130 PMID: 36271199 SCOPUS ID: 2-s2.0-85140356180 10/23/2022
Clinical outcome of patients with relapsed refractory multiple myeloma listed for BCMA directed commercial CAR-T therapy.

(Al Hadidi S, Szabo A, Esselmann J, Hammons L, Hussain M, Ogunsesan Y, Thalambedu N, Khan F, Sethi J, Janardan A, Radhakrishnan SV, Thanendrarajan S, Schinke C, Dhakal B, Janz S, Chhabra S, D'Souza A, Zangari M, van Rhee F, Mohan M.) Bone Marrow Transplant. 2022 Dec 22 PMID: 36550200 SCOPUS ID: 2-s2.0-85144572498 12/23/2022
Racial disparities of delay in diagnosis and dermatologic care for hidradenitis suppurativa.

(Serrano L, Ulschmid C, Szabo A, Roth G, Sokumbi O.) J Natl Med Assoc. 2022 Dec;114(6):613-616 PMID: 36511276 SCOPUS ID: 2-s2.0-85140957723 12/14/2022
Salvage polatuzumab and allogeneic transplant rescues patients with B-cell lymphoma failing CAR T-cell therapy.

(Furqan F, Maring M, Szabo A, Fenske TS, Hamadani M, Shah NN.) Blood Adv. 2022 Nov 23 PMID: 36417762 11/24/2022
Kinetics of Humoral Immunodeficiency With Bispecific Antibody Therapy in Relapsed Refractory Multiple Myeloma.

(Hammons LR, Szabo A, Janardan A, Dhakal B, Chhabra S, D'Souza A, Mohan M.) JAMA Netw Open. 2022 Oct 03;5(10):e2238961 PMID: 36306135 PMCID: PMC9617177 SCOPUS ID: 2-s2.0-85141003728 10/29/2022
Racial disparities of delay in diagnosis and dermatologic care for hidradenitis suppurativa

(Serrano L, Ulschmid C, Szabo A, Roth G, Sokumbi O.) Journal of the National Medical Association. December 2022;114(6):613-616 SCOPUS ID: 2-s2.0-85140957723 12/01/2022